Literature DB >> 8592989

Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.

V N Tariq1, E M Scott, N E McCain.   

Abstract

Interactions between six compounds (econazole, miconazole, amphotericin B, nystatin, nikkomycin Z, and ibuprofen) were investigated for their antifungal activities against Candida albicans by using pair combinations in an in vitro decimal assay for additivity based on disk diffusion. Additive interactions were observed between miconazole and econazole, amphotericin B and nystatin, and amphotericin B and ibuprofen, while an antagonistic interaction was observed between econazole and amphotericin B. Synergistic interactions were recorded for the combinations of econazole and ibuprofen, econazole and nikkomycin Z, and ibuprofen and nikkomycin Z.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592989      PMCID: PMC162999          DOI: 10.1128/AAC.39.12.2615

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Combination therapy in systemic mycosis.

Authors:  A Polak
Journal:  J Chemother       Date:  1990-08       Impact factor: 1.714

2.  Decimal assay for additivity of drugs permits delineation of synergy and antagonism.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

3.  Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.

Authors:  M Pfaller; R Gordee; T Gerarden; M Yu; R Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

4.  Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicans.

Authors:  R F Hector; P C Braun
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

5.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

6.  Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.

Authors:  M M McFarland; E M Scott; A Li Wan Po
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.

Authors:  J Brajtburg; D Kobayashi; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

Review 8.  Impact of the changing epidemiology of fungal infections in the 1990s.

Authors:  M Pfaller; R Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

9.  Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.

Authors:  R F Hector; K Schaller
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

10.  Synergistic action of nikkomycin X/Z with azole antifungals on Candida albicans.

Authors:  S Milewski; F Mignini; E Borowski
Journal:  J Gen Microbiol       Date:  1991-09
View more
  7 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism.

Authors:  Andreza Urba de Quadros; Daniel Bini; Priscilla Aparecida Tartari Pereira; Estela Glória Moroni; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2011-06-29       Impact factor: 2.099

Review 3.  Antimicrobial Effects of Antipyretics.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.

Authors:  R K Li; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  In vitro efficacy of nikkomycin Z against the human isolate of the microsporidian species Encephalitozoon hellem.

Authors:  E Bigliardi; A M Bernuzzi; S Corona; S Gatti; M Scaglia; L Sacchi
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

6.  Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.

Authors:  E M Scott; V N Tariq; R M McCrory
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.

Authors:  Parth N Shah; Kimberly R Marshall-Batty; Justin A Smolen; Jasur A Tagaev; Qingquan Chen; Christopher A Rodesney; Henry H Le; Vernita D Gordon; David E Greenberg; Carolyn L Cannon
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.